Skip to the page

Data / Form D filings / Emblok, Inc.

Emblok, Inc.: Form D filing

Emblok, Inc., a biotechnology company in Tampa, FL, filed a Form D with the SEC in 2026. The latest, on June 18, 2026, reports $6 million sold of a $12 million offering to 1 investor.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
410 S. CEDAR AVE., Tampa, FL, 33606
Phone
(804) 638-8598
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2025
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2140377

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jun 18, 2026New notice$12,000,000$6,000,000$6,000,0001May 21, 2026sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Bradley BrownExecutive Officer
Alan J. SimonianDirector
William M. MerhiDirector

Other biotechnology companies in Florida that filed recently

Every Form D from the week of Jun 15, 2026 · All recent filings in Florida · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Emblok, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.